Definition of target antigens for naturally occurring CD4+ CD25+ regulatory T cells

被引:113
作者
Nishikawa, H
Kato, T
Tawara, I
Saito, K
Ikeda, H
Kuribayashi, K
Allen, PM
Schreiber, RD
Sakaguchi, S
Old, LJ
Shiku, H [1 ]
机构
[1] Mie Univ, Sch Med, Dept Internal Med 2, Tsu, Mie 5148507, Japan
[2] Mie Univ, Sch Med, Dept Bioregulat, Tsu, Mie 5148507, Japan
[3] Washington Univ, Sch Med, Ctr Immunol, Dept Pathol & Immunol, St Louis, MO 63110 USA
[4] Kyoto Univ, Inst Frontier Med Sci, Dept Expt Pathol, Kyoto 6068507, Japan
[5] Mem Sloan Kettering Canc Ctr, Ludwig Inst Canc Res, New York, NY 10021 USA
关键词
D O I
10.1084/jem.20041959
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The antigenic targets recognized by naturally occurring CD4(+)CD25(+) regulatory T cells (T reg cells) have been elusive. We have serologically defined a series of broadly expressed self-antigens derived from chemically induced mouse sarcomas by serological identification of antigens by recombinant expression cloning (SEREX). CD4(+)CD25(+)T cells from mice immunized with SEREX-defined self-antigens had strong suppressive activity on peptide-specific proliferation of CD4(+)CD25(-)T cells and CD8(+)T cells. The suppressive effect was observed without in vitro T cell stimulation. Foxp3 expression in these CD4(+)CD25(+)T cells from immunized mice was 5-10 times greater than CD4(+)CD25(+)T cells derived from naive mice. The suppressive effect required cellular contact and was blocked by anti-glucocorticoid-induced tumor necrosis factor receptor family-related gene antibody. In vitro suppressive activity essentially disappeared 8 wk after the last immunization. However, it was regained by in vitro restimulation with cognate self-antigen protein but not with control protein. We propose that SEREX-defined self-antigens such as those used in this study represent self-antigens that elicit naturally occurring CD4(+)CD25(+) T reg cells.
引用
收藏
页码:681 / 686
页数:6
相关论文
共 30 条
[1]   In vivo instruction of suppressor commitment in naive T cells [J].
Apostolou, I ;
von Boehmer, H .
JOURNAL OF EXPERIMENTAL MEDICINE, 2004, 199 (10) :1401-1408
[2]   Origin of regulatory T cells with known specificity for antigen [J].
Apostolou, I ;
Sarukhan, A ;
Klein, L ;
von Boehmer, H .
NATURE IMMUNOLOGY, 2002, 3 (08) :756-763
[3]   Natural versus adaptive regulatory T cells [J].
Bluestone, JA ;
Abbas, AK .
NATURE REVIEWS IMMUNOLOGY, 2003, 3 (03) :253-257
[4]  
CHEN YT, 2000, PRINCIPLES PRACTICE, P557
[5]   Foxp3 Programs the Development and Function of CD4+CD25+ Regulatory T Cells (Reprinted from vol 4, pg 330-336, 2003) [J].
Fontenot, Jason D. ;
Gavin, Marc A. ;
Rudensky, Alexander Y. .
JOURNAL OF IMMUNOLOGY, 2017, 198 (03) :986-992
[6]   Interleukin 2 signaling is required for CD4+ regulatory T cell function [J].
Furtado, GC ;
de Lafaille, MAC ;
Kutchukhidze, N ;
Lafaille, JJ .
JOURNAL OF EXPERIMENTAL MEDICINE, 2002, 196 (06) :851-857
[7]   Eradication of established tumors by CD8+ T cell adoptive immunotherapy [J].
Hanson, HL ;
Donermeyer, DL ;
Ikeda, H ;
White, JM ;
Shankaran, V ;
Old, LJ ;
Shiku, H ;
Schreiber, RD ;
Allen, PM .
IMMUNITY, 2000, 13 (02) :265-276
[8]   Control of regulatory T cell development by the transcription factor Foxp3 [J].
Hori, S ;
Nomura, T ;
Sakaguchi, S .
SCIENCE, 2003, 299 (5609) :1057-1061
[9]   Thymic selection of CD4+CD25+ regulatory T cells induced by an agonist self-peptide [J].
Jordan, MS ;
Boesteanu, A ;
Reed, AJ ;
Petrone, AL ;
Holenbeck, AE ;
Lerman, MA ;
Naji, A ;
Caton, AJ .
NATURE IMMUNOLOGY, 2001, 2 (04) :301-306
[10]   An essential role for Scurfin in CD4+CD25+ T regulatory cells [J].
Khattri, R ;
Cox, T ;
Yasayko, SA ;
Ramsdell, F .
NATURE IMMUNOLOGY, 2003, 4 (04) :337-342